UnitedHealth Group Inc (NYSE:UNH) Shares Sold by Bailard Inc.

Bailard Inc. lessened its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,284 shares of the healthcare conglomerate’s stock after selling 211 shares during the period. Bailard Inc.’s holdings in UnitedHealth Group were worth $8,724,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc boosted its position in UnitedHealth Group by 1.6% during the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after purchasing an additional 1,073,505 shares in the last quarter. First Bank & Trust lifted its position in shares of UnitedHealth Group by 23.4% in the fourth quarter. First Bank & Trust now owns 490 shares of the healthcare conglomerate’s stock valued at $122,000 after acquiring an additional 93 shares in the last quarter. Heritage Investors Management Corp lifted its position in shares of UnitedHealth Group by 13.7% in the fourth quarter. Heritage Investors Management Corp now owns 48,813 shares of the healthcare conglomerate’s stock valued at $12,160,000 after acquiring an additional 5,885 shares in the last quarter. Ackerman Capital Advisors LLC lifted its position in shares of UnitedHealth Group by 24,812.0% in the fourth quarter. Ackerman Capital Advisors LLC now owns 622,800 shares of the healthcare conglomerate’s stock valued at $2,500,000 after acquiring an additional 620,300 shares in the last quarter. Finally, Excalibur Management Corp lifted its position in shares of UnitedHealth Group by 23.4% in the fourth quarter. Excalibur Management Corp now owns 2,160 shares of the healthcare conglomerate’s stock valued at $538,000 after acquiring an additional 410 shares in the last quarter. 85.62% of the stock is owned by institutional investors.

In other UnitedHealth Group news, Director Frederick William Mcnabb III bought 6,430 shares of the business’s stock in a transaction on Wednesday, May 1st. The shares were purchased at an average price of $233.21 per share, with a total value of $1,499,540.30. Following the completion of the acquisition, the director now directly owns 7,879 shares of the company’s stock, valued at approximately $1,837,461.59. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $229.75, for a total transaction of $2,297,500.00. Following the sale, the director now directly owns 187,663 shares of the company’s stock, valued at approximately $43,115,574.25. The disclosure for this sale can be found here. Insiders have sold 35,000 shares of company stock worth $8,392,500 in the last ninety days. Corporate insiders own 0.82% of the company’s stock.

UNH has been the topic of several research reports. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. SunTrust Banks decreased their target price on UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Raymond James decreased their target price on UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating on the stock in a research report on Wednesday, April 17th. Morgan Stanley cut their target price on UnitedHealth Group from $315.00 to $285.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Finally, Bank of America reissued a “buy” rating and set a $290.00 target price (down from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $290.84.

Shares of UnitedHealth Group stock traded down $1.18 during trading hours on Monday, hitting $242.83. 4,102,600 shares of the company’s stock traded hands, compared to its average volume of 4,902,830. The stock has a 50 day moving average of $244.90. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market cap of $232.28 billion, a P/E ratio of 18.84, a PEG ratio of 1.31 and a beta of 0.62. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, beating the consensus estimate of $3.60 by $0.13. The company had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The company’s revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $3.04 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Inc will post 14.71 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a dividend of $1.08 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.90. The ex-dividend date was Friday, June 14th. This represents a $4.32 annualized dividend and a dividend yield of 1.78%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Oversold

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.